Skip to content

Clinical trials

Observational Cholangiocarcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Observational Clear all

158 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20063
20071
20081
20091
20101
20115
20123
20137
20144
20156
20165
20178
20188
20193
202013
202110
202213
20239
202430
202514
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting39
Unknown status34
Not yet recruiting16
Terminated10
Withdrawn6
Active, not recruiting4
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic6
City of Hope Medical Center5
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University4
Weill Medical College of Cornell University4
Assistance Publique - Hôpitaux de Paris3
First Affiliated Hospital, Sun Yat-Sen University3
Imperial College London3
Peking Union Medical College Hospital3
Seoul National University Hospital3
Alaunos Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma158
Carcinoma, Hepatocellular42
Pancreatic Neoplasms39
Liver Neoplasms31
Gallbladder Neoplasms18
Biliary Tract Neoplasms17
Bile Duct Neoplasms15
Stomach Neoplasms15
Colorectal Neoplasms13
Klatskin Tumor12

Trials

Showing 51 to 75 of 158. Each trial links to its page on Pharma Observatory.

58 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.